Marcus Breden
0000-0002-3152-614X
1 paper found
Refreshing results…
Defactinib, Pembrolizumab, and Gemcitabine in Patients with Advanced Treatment Refractory Pancreatic Cancer: A Phase I Dose Escalation and Expansion Study
Missing publications? Search for publications with a matching author name.